MCID: PRS063
MIFTS: 39

Paresthesia

Categories: Neuronal diseases, Skin diseases

Aliases & Classifications for Paresthesia

MalaCards integrated aliases for Paresthesia:

Name: Paresthesia 54 29 6 73

Classifications:



External Ids:

UMLS 73 C0030554

Summaries for Paresthesia

NINDS : 54 Paresthesia refers to a burning or prickling sensation that is usually felt in the hands, arms, legs, or feet, but can also occur in other parts of the body. The sensation, which happens without warning, is usually painless and described as tingling or numbness, skin crawling, or itching. Most people have experienced temporary paresthesia -- a feeling of "pins and needles" -- at some time in their lives when they have sat with legs crossed for too long, or fallen asleep with an arm crooked under their head. It happens when sustained pressure is placed on a nerve. The feeling quickly goes away once the pressure is relieved. Chronic paresthesia is often a symptom of an underlying neurological disease or traumatic nerve damage. Paresthesia can be caused by disorders affecting the central nervous system, such as stroke and transient ischemic attacks (mini-strokes), multiple sclerosis, transverse myelitis, and encephalitis. A tumor or vascular lesion pressed up against the brain or spinal cord can also cause paresthesia. Nerve entrapment syndromes, such as carpal tunnel syndrome, can damage peripheral nerves and cause paresthesia accompanied by pain. Diagnostic evaluation is based on determining the underlying condition causing the paresthetic sensations. An individual's medical history, physical examination, and laboratory tests are essential for the diagnosis. Physicians may order additional tests depending on the suspected cause of the paresthesia.

MalaCards based summary : Paresthesia is related to polyglucosan body myopathy 1 with or without immunodeficiency and facial diplegia with paresthesias, and has symptoms including hyperesthesia, dysesthesia and hyperalgesia. An important gene associated with Paresthesia is FKRP (Fukutin Related Protein). The drugs Bupivacaine and Levobupivacaine have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, skin and testes.

Wikipedia : 76 Paresthesia is an abnormal dermal sensation (e.g., a tingling, pricking, chilling, burning, or numb... more...

Related Diseases for Paresthesia

Diseases related to Paresthesia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 93)
# Related Disease Score Top Affiliating Genes
1 polyglucosan body myopathy 1 with or without immunodeficiency 29.5 CAPN3 FKRP
2 facial diplegia with paresthesias 12.2
3 carpal tunnel syndrome 11.4
4 multiple sclerosis 11.4
5 fibromyalgia 11.2
6 hypocalcemia, autosomal dominant 1 11.2
7 thoracic outlet syndrome 11.1
8 notalgia paresthetica 11.1
9 brachyolmia type 3 10.9
10 neurofibromatosis, familial spinal 10.9
11 neuropathy, hereditary sensory and autonomic, type ia 10.9
12 pernicious anemia 10.9
13 pruritus, hereditary localized 10.9
14 multiple sclerosis 3 10.9
15 multiple sclerosis 5 10.9
16 hypocalcemia, autosomal dominant 2 10.9
17 tabes dorsalis 10.9
18 radial neuropathy 10.9
19 neuritis 10.9
20 spondylosis 10.9
21 herpes zoster 10.9
22 mitochondrial neurogastrointestinal encephalopathy disease 10.9
23 adult-onset nemaline myopathy 10.9
24 cramp-fasciculation syndrome 10.9
25 lipedematous scalp 10.9
26 whiplash 10.9
27 guillain-barre syndrome 10.1
28 mononeuropathy of the median nerve, mild 10.1
29 dermatitis 10.1
30 cerebral amyloid angiopathy, cst3-related 10.0
31 hypophosphatemia 10.0
32 polyneuropathy 10.0
33 contact dermatitis 10.0
34 allergic contact dermatitis 10.0
35 herpes simplex 10.0
36 neuropathy 10.0
37 depression 10.0
38 pain - chronic 10.0
39 autosomal recessive limb-girdle muscular dystrophy 9.9 CAPN3 FKRP
40 autosomal recessive limb-girdle muscular dystrophy type 2j 9.9 CAPN3 FKRP
41 limb-girdle muscular dystrophy 9.9 CAPN3 FKRP
42 muscular dystrophy 9.9 CAPN3 FKRP
43 autosomal recessive limb-girdle muscular dystrophy type 2d 9.9 CAPN3 FKRP
44 autosomal recessive limb-girdle muscular dystrophy type 2h 9.8 CAPN3 FKRP
45 isolated hyperckemia 9.8 CAPN3 FKRP
46 autosomal recessive limb-girdle muscular dystrophy type 2a 9.8 CAPN3 FKRP
47 muscular dystrophy, limb-girdle, autosomal recessive 8 9.8 CAPN3 FKRP
48 muscular dystrophy, limb-girdle, autosomal recessive 7 9.8 CAPN3 FKRP
49 breast cancer 9.8
50 pneumothorax, primary spontaneous 9.8

Graphical network of the top 20 diseases related to Paresthesia:



Diseases related to Paresthesia

Symptoms & Phenotypes for Paresthesia

UMLS symptoms related to Paresthesia:


hyperesthesia, dysesthesia, hyperalgesia, numbness, circumoral paresthesia, paresthesia, distal, paresthesia mucosal, paresthesia skin, tingling of skin, burning sensation of skin, burning mucosal, paresthesia mouth, electric shock sensation, skin sensation disturbance, tingling mucosal, back paresthesia, buttock paresthesia, extremity paresthesia, facial paresthesia, facial paresthesia, unilateral, finger paresthesia, lip paresthesia, nose paresthesia, palmar pain, palmar paresthesia, thigh numbness, thigh paresthesia, trunk paresthesia, abnormal sensation, pins and needles, paresthesia upper limb, stinging sensation, painful paresthesias, paresthesia lower limb, has tingling sensation

Drugs & Therapeutics for Paresthesia

Drugs for Paresthesia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 542)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bupivacaine Approved, Investigational Phase 4,Phase 1,Not Applicable 2180-92-9, 38396-39-3 2474
2
Levobupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 27262-47-1 92253
3
Ropivacaine Approved Phase 4,Phase 3,Phase 2,Not Applicable 84057-95-4 175805 71273
4
Diclofenac Approved, Vet_approved Phase 4,Phase 2,Not Applicable 15307-86-5 3033
5
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 137-58-6 3676
6
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 329-65-7 838
7
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-43-4 5816
8
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 1177-87-3
9
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-02-2 5743
10
Mepivacaine Approved, Vet_approved Phase 4,Not Applicable 96-88-8 4062
11
Ketorolac Approved Phase 4,Not Applicable 66635-83-4, 74103-06-3 3826
12
Triamcinolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 124-94-7 31307
13
gamma-Aminobutyric acid Approved, Investigational Phase 4,Phase 2 56-12-2 119
14
Gabapentin Approved, Investigational Phase 4,Phase 2,Not Applicable 60142-96-3 3446
15
Oxaliplatin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 61825-94-3 43805 6857599 5310940 9887054
16
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1 51-21-8 3385
17
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 58-05-9 6006 143
18
Acetazolamide Approved, Vet_approved Phase 4,Not Applicable 59-66-5 1986
19
Dexmedetomidine Approved, Vet_approved Phase 4,Not Applicable 113775-47-6 68602 5311068
20
Acyclovir Approved Phase 4,Phase 3,Phase 2 59277-89-3 2022
21
Penciclovir Approved Phase 4 39809-25-1 4725
22
Nicotinamide Approved, Investigational Phase 4,Phase 3 98-92-0 936
23
Acetaminophen Approved Phase 4,Phase 2,Not Applicable,Early Phase 1 103-90-2 1983
24
Ibuprofen Approved Phase 4 15687-27-1 3672
25
Propiverine Approved, Investigational Phase 4 60569-19-9 4942
26
rituximab Approved Phase 4,Phase 2,Phase 1,Not Applicable 174722-31-7 10201696
27
Methotrexate Approved Phase 4 59-05-2, 1959-05-2 126941
28
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 2,Phase 1 302-25-0
29
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-24-8 5755
30
Methylprednisolone hemisuccinate Approved Phase 4,Phase 2,Phase 1 2921-57-5
31
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 1 83-43-2 6741
32
Nitrous oxide Approved, Vet_approved Phase 4,Phase 3,Phase 2 10024-97-2 948
33
Desogestrel Approved Phase 4 54024-22-5 40973
34
Etonogestrel Approved, Investigational Phase 4 54048-10-1 6917715 40976
35
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-41-2 439260
36
Dimethyl fumarate Approved, Investigational Phase 4,Phase 3,Not Applicable 624-49-7 637568 5271565
37
Aspirin Approved, Vet_approved Phase 4,Phase 3 50-78-2 2244
38
Doxycycline Approved, Investigational, Vet_approved Phase 4,Not Applicable 564-25-0 54671203
39
Cefuroxime Approved Phase 4,Not Applicable 55268-75-2 5361202 5479529
40
Pseudoephedrine Approved Phase 4 90-82-4 7028
41
Phenylephrine Approved Phase 4 59-42-7 6041
42
Oxymetazoline Approved, Investigational Phase 4 1491-59-4 4636
43
Ephedrine Approved Phase 4 299-42-3 9294
44
Morphine Approved, Investigational Phase 4,Phase 3,Not Applicable 57-27-2 5288826
45
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Not Applicable 437-38-7 3345
46
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 148553-50-8 5486971
47
Oxycodone Approved, Illicit, Investigational Phase 4,Phase 3,Not Applicable 76-42-6 5284603
48
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
49
Famciclovir Approved, Investigational Phase 4,Phase 3,Not Applicable 104227-87-4 3324
50
Dopamine Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-61-6, 62-31-7 681

Interventional clinical trials:

(show top 50) (show all 693)
# Name Status NCT ID Phase Drugs
1 Spinal Cord Stimulation (SCS) in Refractory Angina Unknown status NCT00121654 Phase 4
2 The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance Unknown status NCT02329379 Phase 4 Levothyroxine
3 Comparison of 1000 Hertz (Hz), Burst, and Standard Spinal Cord Stimulation in Chronic Pain Relief Unknown status NCT02902796 Phase 4
4 Optimal Volume of Bupivacaine in Adductor Canal Nerve Block Unknown status NCT02557386 Phase 4 Levobupivacaine 5 mL;Levobupivacaine 10 mL;Levobupivacaine 15 mL;Levobupivacaine 20 mL;Levobupivacaine 25 mL;Levobupivacaine 30 mL
5 Ultrasound Guided Pectoral Nerve I and II Blocks in Multimodal Analgesia for Breast Surgery Unknown status NCT02672813 Phase 4
6 Efficacy of Gabapentin in the Treatment of Chest Pain and Paresthesia in Patients With Sternotomy Completed NCT00800527 Phase 4 Gabapentin;Diclofenac
7 Safety of Two Epidural Catheters in Thoracic Epidural Anaesthesia (TEA) Completed NCT00394459 Phase 4
8 Optimized Programming in Spinal Cord Stimulation (SCS) System Completed NCT00871819 Phase 4
9 Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer Completed NCT02284529 Phase 4 Orectalip
10 Changes in Cerebral Blood Flow in Patients Treated With Spinal Cord Stimulation for Low Back and Leg Pain Completed NCT00418301 Phase 4
11 Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing Completed NCT01993667 Phase 4 Acetazolamide
12 Postoperative Alpha Lipoic Acid in the Carpal Tunnel Syndrome: a Randomized Controlled Trial. Completed NCT01895621 Phase 4
13 Alpha Lipoic Acid for Treatment of Diabetic Neuropathy Completed NCT02439879 Phase 4 Alpha lipoic acid
14 Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Block (ADRIB Trial) Completed NCT02630290 Phase 4 Ropivacaine;Ropivacaine + Dexmedetomidine
15 Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients. Completed NCT01997489 Phase 4 Enzyme replacement
16 Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency Completed NCT00835822 Phase 4 Venocur Triplex®;placebo
17 Efficacy Study of the Octapolar Lead in Patients With Failed Back Surgery Syndrome (FBSS) With Chronic Pain Completed NCT01096147 Phase 4
18 A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers Completed NCT00820534 Phase 4 Penciclovir;Placebo
19 Myofascial Release on Electrophysiological Measures of Pregnant Women With CTS Completed NCT03802448 Phase 4
20 Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Completed NCT00913081 Phase 4
21 Ibuprofen vs Acetaminophen for AMS Prevention Completed NCT02244437 Phase 4 Ibuprofen;Acetaminophen
22 Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder Completed NCT00903045 Phase 4 Propiverine hydrochloride;Placebo
23 Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis Completed NCT01593332 Phase 4 Rituximab;Rituximab
24 Efficacy Study of Local Steroid Injection and Wrist Splinting for Carpal Tunnel Syndrome Completed NCT02140632 Phase 4
25 β-alanine Supplementation on Knee Extensor Contractile and Force Properties Completed NCT02819505 Phase 4
26 Bispectral Index and Clinical Parameters Evaluation in Dental Procedures Completed NCT02671578 Phase 4 Nitrous Oxide
27 Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant Completed NCT00847587 Phase 4 Etonogestrel contraceptive implant;Etonogestrel contraceptive implant
28 Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD) Completed NCT01056289 Phase 4 Desvenlafaxine Succinate Sustained-Release Formulation 50 mg;Desvenlafaxine Succinate Sustained-Release Formulation 25 mg;Placebo
29 Thiamin Deficiency in Obese Thai Children Completed NCT02464865 Phase 4 Thiamine 1;Thiamine 2
30 Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006) Completed NCT02256553 Phase 4 Rescue Medication
31 Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis Completed NCT02090413 Phase 4 dimethyl fumarate;acetylsalicylic acid;ASA-Placebo
32 Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome Completed NCT01518192 Phase 4 doxycycline;cefuroxime axetil
33 Efficacy of Interscalene Brachial Plexus Block With Liposomal Bupivacaine for Arthroscopic Shoulder Surgery Completed NCT01977352 Phase 4 Liposomal bupivacaine;Bupivacaine 0.25%
34 Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous Insufficiency Completed NCT01848210 Phase 4 Coumarin/troxerutin;Placebo
35 Perineural Steroids for Peripheral Nerve Blocks Completed NCT02462148 Phase 4 Dexamethasone;Bupivacaine;Epinephrine
36 Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea Completed NCT03380390 Phase 4 Oxymetazoline HCL 1.0% Cream
37 Ultrasound Guidance for Interscalene Brachial Plexus Block Completed NCT00702416 Phase 4 Ropivacaine;Paracetamol;Morphine;Fentanyl
38 Ultrasound Plus Nerve Stimulator Versus Nerve Stimulator Guided Lumbar Plexus Block Completed NCT02020096 Phase 4
39 Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin Completed NCT01352741 Phase 4 Tapentadol Prolonged Release;Tapentadol Prolonged Release with Pregabalin;Tapentadol Prolonged Release open label maintenance
40 Ropivacaine Continuous Wound Infusion Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery Completed NCT03502642 Phase 4 intrathecal morphine;Ropivacaine (Ropivacaina Molteni®);Normal saline
41 Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component. Completed NCT01838616 Phase 4 Tapentadol Prolonged Release;Oxycodone/Naloxone Prolonged Release
42 The Retroclavicular Approach for Regional Anesthesia of the Upper Limb in Obese Patients Completed NCT02086643 Phase 4
43 Tissue Glue (Cyanoacrylate) Versus Conventional Suture in Kidney Donors Completed NCT01521871 Phase 4
44 Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients Completed NCT00477334 Phase 4 Famciclovir;Placebo
45 A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP) Completed NCT02417935 Phase 4 Duloxetine;Pregabalin;Placebo
46 Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients Completed NCT01502787 Phase 4 Metoprolol succinate;Nebivolol;Angiotensin II
47 The Retroclavicular Approach for Regional Anesthesia Completed NCT01852396 Phase 4
48 Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management Completed NCT01364298 Phase 4 Gabapentin/B-complex;Pregabalin
49 Effect of Dexamethasone Dose and Route on Duration of Interscalene Block After Outpatient Shoulder Surgery Completed NCT02426736 Phase 4 Dexamethasone;Bupivacaine
50 Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain Completed NCT00313820 Phase 4 Pregabalin;Placebo

Search NIH Clinical Center for Paresthesia

Genetic Tests for Paresthesia

Genetic tests related to Paresthesia:

# Genetic test Affiliating Genes
1 Paresthesia 29

Anatomical Context for Paresthesia

MalaCards organs/tissues related to Paresthesia:

41
Spinal Cord, Skin, Testes, Brain, Bone, Liver, Cortex

Publications for Paresthesia

Articles related to Paresthesia:

(show top 50) (show all 316)
# Title Authors Year
1
Sub-paresthesia spinal cord stimulation reverses thermal hyperalgesia and modulates low frequency EEG in a rat model of neuropathic pain. ( 29740068 )
2018
2
Extending Coronectomy Indications to Third Molars with Taurodontism to Prevent Paresthesia and Mandible Fracture. ( 29808127 )
2018
3
The Anatomical Nature of Dental Paresthesia: A Quick Review. ( 29541262 )
2018
4
Spinal Cord Stimulation for Treating Chronic Pain: Reviewing Preclinical and Clinical Data on Paresthesia-Free High-Frequency Therapy. ( 29105244 )
2018
5
Risk factors for hypertrophic burn scar pain, pruritus, and paresthesia development. ( 29719102 )
2018
6
Role of Panoramic Imaging and Cone Beam CT for Assessment of Inferior Alveolar Nerve Exposure and Subsequent Paresthesia Following Removal of Impacted Mandibular Third Molar. ( 29618893 )
2018
7
Low-level laser therapy may reduce the time of recovery from paresthesia after orthognathic surgery. ( 29221612 )
2018
8
Paresthesia frequency in fibromyalgia and its effects on personality traits. ( 29968325 )
2018
9
Delayed paresthesia of inferior alveolar nerve after dental surgery: case report and related pathophysiology. ( 29984322 )
2018
10
Slurring of Speech and Lip Paresthesia: Symptoms of Levodopa End of Dose Wearing Off in Parkinson's Disease. ( 30237947 )
2018
11
Cutaneous paresthesia after internal plate fixation of clavicle fractures and underlying anatomical observations. ( 30313074 )
2018
12
Case 34-2018: A 58-Year-Old Woman with Paresthesia and Weakness of the Left Foot and Abdominal Wall. ( 30403952 )
2018
13
Influence of Electroacupuncture and Laser-Acupuncture on Treating Paresthesia in Patients Submitted to Combined Orthognathic Surgery and Genioplasty. ( 29067139 )
2017
14
Electroacupuncture Therapy for Auricular Paresthesia. ( 29067145 )
2017
15
Clinical Paresthesia Atlas Illustrates Likelihood of Coverage Based on Spinal Cord Stimulator Electrode Location. ( 28370724 )
2017
16
Clinical Reasoning: A 71-year-old woman with subacute progressive distal weakness and paresthesia after vaccination. ( 28438848 )
2017
17
Does the Surgical Management of the Intercostobrachial Nerve Influence the Postoperatory Paresthesia of the Upper Limb and Life Quality in Breast Cancer Patients? ( 28862120 )
2017
18
Guillain-BarrAc Syndrome: A Variant Consisting of Facial Diplegia and Paresthesia with Left Facial Hemiplegia Associated with Antibodies to Galactocerebroside and Phosphatidic Acid. ( 28966341 )
2017
19
Reversed Palmaris Longus Muscle CausingA Volar Forearm Pain and UlnarA Nerve Paresthesia. ( 27964899 )
2017
20
Paresthesia-Independence: An Assessment of Technical Factors Related to 10 kHz Paresthesia-Free Spinal Cord Stimulation. ( 28535555 )
2017
21
Effect of Acupuncture on Post-implant Paresthesia. ( 28483185 )
2017
22
Persistent lingual paresthesia caused by a displaced tooth fragment: a case report and literature review. ( 29354592 )
2017
23
Comparison between Steroid Injection and Stretching Exercise on the Scalene of Patients with Upper Extremity Paresthesia: Randomized Cross-Over Study. ( 26847305 )
2016
24
Primary somatosensory/motor cortical thickness distinguishes paresthesia-dominant from pain-dominant carpal tunnel syndrome. ( 26761384 )
2016
25
Acetabular Paralabral Cyst: An Unusual Cause of Lower Extremity Pain and Paresthesia. ( 26721454 )
2016
26
Nerve Fiber Activation During Peripheral Nerve Field Stimulation: Importance of Electrode Orientation and Estimation of Area of Paresthesia. ( 26586248 )
2016
27
High-Frequency Stimulation of Dorsal Column Axons: Potential Underlying Mechanism of Paresthesia-Free Neuropathic Pain Relief. ( 27145196 )
2016
28
Odontogenic keratocysts in the Basal Cell Nevus (Gorlin-Goltz) Syndrome associated with paresthesia of the lower jaw: Case report, retrospective analysis of a representative Czech cohort and recommendations for the early diagnosis. ( 27857042 )
2016
29
Reducing Adverse Effects During Drug Development: The Example of Lesogaberan and Paresthesia. ( 26947796 )
2016
30
Exercising Impacts on Fatigue, Depression, and Paresthesia in Female Patients with Multiple Sclerosis. ( 26656775 )
2016
31
Rare case of small size Extraskeletal Ewing Sarcoma arising from the median nerve with paresthesia. ( 27523258 )
2016
32
Evaluation of pulsing magnetic field effects on paresthesia in multiple sclerosis patients, a randomized, double-blind, parallel-group clinical trial. ( 27556294 )
2016
33
Clinical Outcomes of 1 kHz Subperception Spinal Cord Stimulation in Implanted Patients With Failed Paresthesia-Based Stimulation: Results of a Prospective Randomized Controlled Trial. ( 27186822 )
2016
34
Facial Diplegia with Paresthesia: An Uncommon Variant of Guillain-Barre Syndrome. ( 27630886 )
2016
35
Infection Related Inferior Alveolar Nerve Paresthesia in the Lower Premolar Teeth. ( 27597904 )
2016
36
Topiramate-induced paresthesia is more frequently reported by migraine than epileptic patients. ( 26809953 )
2016
37
Home Use of a Pyrethroid-Containing Pesticide and Facial Paresthesia in a Toddler: A Case Report. ( 27548193 )
2016
38
Left Chin Paresthesia in an Elderly Man-An Unusual But Ominous Variety of Neuralgia. ( 27317228 )
2016
39
Paresthesia and sensory disturbances associated with 2009 pandemic vaccine receipt: Clinical features and risk factors. ( 26209839 )
2015
40
Characteristic Findings on Panoramic Radiography and Cone-beam CT to Predict Paresthesia after Extraction of Impacted Third Molar. ( 25765570 )
2015
41
How Can Paresthesia After Zygomaticomaxillary Complex Fracture Be Determined After Long-Term Follow-Up? A New and Quantitative Evaluation Method Using Current Perception Threshold Testing. ( 25865713 )
2015
42
Laser Therapy in the Treatment of Paresthesia: A Retrospective Study of 125 Clinical Cases. ( 26226172 )
2015
43
Endodontic periapical lesion-induced mental nerve paresthesia. ( 25878687 )
2015
44
Recurrent Spontaneous Paresthesia in the Upper Limb Could Be Due to Migraine: A Case Series. ( 26234162 )
2015
45
Paresthesia: A Review of Its Definition, Etiology and Treatments in View of the Traditional Medicine. ( 26561077 )
2015
46
Performance effects of acute I^-alanine induced paresthesia in competitive cyclists. ( 25636080 )
2015
47
Report of Transient Paresthesia Following Transcranial Stimulation. ( 26050601 )
2015
48
Massive mandibular destruction and alveolar nerve infiltration without lower lip paresthesia in primary intraosseous carcinoma: report of two cases and critical appraisal of diagnostic criteria. ( 25485318 )
2015
49
65-year-old woman with intermittent fevers, lower extremity paresthesia, weight loss, and malaise. Glomerulonephritis. ( 25939938 )
2015
50
A 64-year old woman with right hand swelling and paresthesia. ( 26233638 )
2015

Variations for Paresthesia

ClinVar genetic disease variations for Paresthesia:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 FKRP NM_024301.4(FKRP): c.826C> A (p.Leu276Ile) single nucleotide variant Pathogenic rs28937900 GRCh37 Chromosome 19, 47259533: 47259533
2 FKRP NM_024301.4(FKRP): c.826C> A (p.Leu276Ile) single nucleotide variant Pathogenic rs28937900 GRCh38 Chromosome 19, 46756276: 46756276
3 CAPN3; SGCB NM_000070.2(CAPN3): c.550delA (p.Thr184Argfs) deletion Pathogenic rs80338800 GRCh37 Chromosome 15, 42680002: 42680002
4 CAPN3; SGCB NM_000070.2(CAPN3): c.550delA (p.Thr184Argfs) deletion Pathogenic rs80338800 GRCh38 Chromosome 15, 42387804: 42387804
5 CAPN3 NM_000070.2(CAPN3): c.1746-20C> G single nucleotide variant Conflicting interpretations of pathogenicity rs201892814 GRCh37 Chromosome 15, 42695919: 42695919
6 CAPN3 NM_000070.2(CAPN3): c.1746-20C> G single nucleotide variant Conflicting interpretations of pathogenicity rs201892814 GRCh38 Chromosome 15, 42403721: 42403721
7 MT-ND6 NC_012920.1: m.14477A> G single nucleotide variant Uncertain significance GRCh37 Chromosome MT, 14477: 14477
8 MT-ND6 NC_012920.1: m.14477A> G single nucleotide variant Uncertain significance GRCh38 Chromosome MT, 14477: 14477

Expression for Paresthesia

Search GEO for disease gene expression data for Paresthesia.

Pathways for Paresthesia

GO Terms for Paresthesia

Sources for Paresthesia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....